The aim of the current study was to estimate the proportion of variance in cognitive functions mediated by pre-clinical neurodegeneration (measured by serum NfL), in order to gain a better understanding of the utility of serum NfL as a biomarker of pre-clinical cognitive decline. The gene discussed is NEFL; the disease is Mental deterioration.